The Chairman and CEO of Pfizer announced on Tuesday, May 4, that it expects the FDA to expand Emergency Use Authorization, allowing children ages 12-15 to receive its vaccine. Previously, the cut-off age was 16, but Pfizer has stated that the results of testing of its vaccine will allow the younger-aged children to safely receive the vaccine. Pfizer expects FDA approval as early as next week.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.